CD9 and melanoma: Besides its physiological functions, CD9 is widely associated with diseases: both the up-regulation and down-regulation of CD9 are linked with poor prognosis in several types of cancer, such as melanoma, leukemia, and gastric, lung, breast, colon, and prostate malignancies (Brosseau et al, 2018).